C
CERO//CIK 0001870404
CERO THERAPEUTICS HOLDINGS, INC.
Market Data
$0.01−$0.00 (−8.33%)
CERO · Last trade
Prev Close
$0.01
Range (30d)
$0.01 – $0.01
Recent Filings
- 8-K618.5 KBCERO THERAPEUTICS HOLDINGS, INC.Aug 31, 4:52 PM ET·0001213900-26-095776
- 10-Q8.3 MBCERO THERAPEUTICS HOLDINGS, INC.Aug 14, 4:06 PM ET·0001213900-26-090030
- SCHEDULE 13G/A6.2 KBCERO THERAPEUTICS HOLDINGS, INC.Aug 14, 4:00 PM ET·0001376474-26-000565
- 8-K337.3 KBCERO THERAPEUTICS HOLDINGS, INC.Jul 17, 4:37 PM ET·0001213900-26-079207
- 8-K333.6 KBCERO THERAPEUTICS HOLDINGS, INC.Jun 26, 4:05 PM ET·0001213900-26-072602
- 8-K248.8 KBCERO THERAPEUTICS HOLDINGS, INC.May 29, 4:05 PM ET·0001213900-26-062802
- 10-Q7.6 MBCERO THERAPEUTICS HOLDINGS, INC.May 15, 4:12 PM ET·0001213900-26-057753
- 8-K245.6 KBCERO THERAPEUTICS HOLDINGS, INC.May 1, 4:10 PM ET·0001213900-26-050951
- 10-K/A761.0 KBCERO THERAPEUTICS HOLDINGS, INC.Apr 30, 4:34 PM ET·0001213900-26-050302
- 10-K14.6 MBCERO THERAPEUTICS HOLDINGS, INC.Apr 15, 4:05 PM ET·0001213900-26-044040
Insiders
10- ATWOOD BRIAN GDirector
- Byrnes MichaelDirector
- Carter Charles RossChief Financial Officer
- Corey DanielDirector, Chief Technical Officer
- Ehrlich Christopher BDirector, Chairman and CEO
- Fisher Douglas CarlPresident
- Francois EricDirector
- Geffken Daniel E.Chief Financial Officer
- Kosacz BarbaraDirector
- KUCHARCHUK ANDREW ALBERTChief Financial Officer
Tickers
Addresses
business
201 HASKINS WAY SUITE 230
SOUTH SAN FRANCISCO, CA, 94080
mailing
201 HASKINS WAY SUITE 230
SOUTH SAN FRANCISCO, CA, 94080
Former Names
- CERO THERAPEUTICS HOLDINGS, INC.2026-08-31
- PHOENIX BIOTECH ACQUISITION CORP.2024-02-14